LeMaitre Vascular Announces Details for Its November 12th & 13th Investor and Analyst Days

LeMaitre Vascular, Inc. Logo

BURLINGTON, Mass., Nov. 6, 2013 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of peripheral vascular devices and implants, announced today that it will webcast its investor and analyst days to be held on November 12th and 13th. These events will be hosted and webcast live from two locations:

  • Tuesday, November 12, 9:30 AM to 1:00 PM EST, Corporate Headquarters, Burlington, MA
  • Wednesday, November 13, 9:30 AM to 12:30 PM PST, One Market Restaurant, San Francisco, CA

These two events are open to all investors and analysts. They will feature presentations by senior management who will discuss the Company's positioning, overall corporate strategy and growth opportunities followed by question and answer sessions. During the events, the Company plans to reiterate its financial outlook for the fourth quarter and full year 2013 that it previously announced on October 29, 2013. Those who attend in Burlington, MA, will have the opportunity to participate in manufacturing facility tours and product demonstrations in the Company's R&D lab.

To RSVP for in-person attendance, please email Mary Nielson at mnielson@lemaitre.com.

The webcasts will be available live on the Investor Relations page of the Company's website at www.lemaitre.com/investor. A recorded replay of each webcast will be available on the same Investor Relations page shortly after the conclusion of each event.

About LeMaitre Vascular

LeMaitre Vascular is a provider of devices and implants for the treatment of peripheral vascular disease, a condition that affects more than 20 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. The Company's diversified product portfolio consists of brand name devices used in arteries and veins outside of the heart. Additional information can be found at http://www.lemaitre.com.

LeMaitre and the LeMaitre Vascular logo are registered trademarks of LeMaitre Vascular, Inc.

Forward-Looking Statements

Statements made in this release may be forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Such "forward-looking statements" regarding the Company's business that are not historical facts may involve risks and uncertainties. Forward-looking statements are based on management's current, preliminary expectations and are subject to risks and uncertainties that could cause actual results to differ from the results predicted. These risks and uncertainties include, but are not limited to, the risk that the Company may not realize the anticipated benefits of its strategic activities and other risks and uncertainties included under the heading "Risk Factors" in its most recent Annual Report on Form 10-K, as updated by its subsequent filings with the SEC, all of which are available on the Company's investor relations website at http://www.lemaitre.com and on the SEC's website at http://www.sec.gov. Undue reliance should not be placed on forward-looking statements, which speak only as of the date they are made. The Company undertakes no obligation to update publicly any forward-looking statements to reflect new information, events, or circumstances after the date they were made, or to reflect the occurrence of unanticipated events.

CONTACT: LeMaitre Vascular, Inc. Mary Nielson +1-781-425-1659 mnielson@lemaitre.com http://www.lemaitre.com

Source:LeMaitre Vascular, Inc.